Download PDF
Thromb Haemost 1994; 72(04): 643-644
DOI: 10.1055/s-0038-1648928
Letter to the Editor
Schattauer GmbH Stuttgart

Treatment of Acquired von Willebrand Syndrome with Intravenous Immunoglobulin

Yale S Arkel
The Blood Disorder Center, Overlook Hospital, Summit, NJ, USA
,
Jean Lynch
The Blood Disorder Center, Overlook Hospital, Summit, NJ, USA
,
Mikio Kamiyama
The Blood Disorder Center, Overlook Hospital, Summit, NJ, USA
› Author Affiliations
Further Information

Publication History

Received 23 February 1994

Accepted after resubmission 16 June 1994

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Mannucci PM, Lombardi R, Bader R, Horellou MH, Finazzi G, Besana C, Conard J, Samama M. Studies of the pathophysiology of acquired von Willebrand’s Disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies. Blood 1984; 64: 614-621
    CrossrefPubMedGoogle Scholar
  • 2 Handin RI, Martin V, Moloney WC. Antibody-induced von Willebrand,s disease: A newly defined inhibitor syndrome. Blood 1976; 48: 393-405
    PubMedGoogle Scholar
  • 3 Simone JV, Cornet JA, Abildgaard CF. Acquired von Willebrand,s syndrome in systemic lupus erythematosus. Blood 1968; 31: 806-812
    PubMedGoogle Scholar
  • 4 Joist JH, Cowan JF, Zimmerman TS. Acquired von Willebrand,s disease, evidence for a quantitative and qualitative factor VIII deficiency. New Eng J Med 1978; 298: 988-991
    CrossrefPubMedGoogle Scholar
  • 5 McGrath KM, Johnson CA, Stuart JJ. Acquired von Willebrand,s disease associated with an inhibitor to Factor VIII antigen and gastrointestinal telangiectasia. Am J Med 1979; 67: 693-696
    CrossrefPubMedGoogle Scholar
  • 6 Meyer D, Frommel D, Larrieu MJ, Zimmerman TS. Selective absence of large forms of factor VUI/von Willebrand factor in acquired von Willebrand,s syndrome. Response to transfusion. Blood 1970; 54: 600-606
    PubMedGoogle Scholar
  • 7 Sampson BM, Greaves M, Malia RG, Preston FE. Acquired von Willebrand,s disease: Demonstration of a circulating inhibitor to the factor VIII complex in four cases. Br J Haematol 1983; 54: 233-244
    CrossrefPubMedGoogle Scholar
  • 8 Stableforth P, Tamagnini GL, Dormandy KM. Acquired von Willebrand,s syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation. Br J Haematol 1976; 33: 565-573
    CrossrefPubMedGoogle Scholar
  • 9 Hanley D, Arkel YS, Lynch J, Kamiyama M. Acquired von Willebrand,s Syndrome in Association with a Lupus-Like Anticoagulant Corrected by Intravenous Immunoglobulin. Am J Hematol 1994; 46: 141-146
    CrossrefPubMedGoogle Scholar
  • 10 Delmer A, Horellou MH, Brechot JM, Prudent J, Potevin F, Lecrubier C, Girard-Longhini C, Samama M, Zittoun R. Acquired von Willebrand,s disease: Correction of hemostatic defect by high-dose intravenous immunoglobulins. Am J Hematol 1992; 40: 151-152
    CrossrefPubMedGoogle Scholar
  • 11 White LA, Chisholm M. Gastro-intestinal bleeding in acquired von Willebrand,s disease: efficacy of high-dose immuno-globulin where substitution treatment failed. Br J Haematol 1993; 84: 332-334
    CrossrefPubMedGoogle Scholar